Search

Your search keyword '"Morris, Jc"' showing total 73 results

Search Constraints

Start Over You searched for: Author "Morris, Jc" Remove constraint Author: "Morris, Jc" Database OAIster Remove constraint Database: OAIster
73 results on '"Morris, Jc"'

Search Results

1. Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease

2. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease

3. Biomarker clustering in autosomal dominant Alzheimer's disease

4. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

5. The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives

6. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease

7. A deep learning framework identifies dimensional representations of Alzheimer's Disease from brain structure

8. Deep Generative Medical Image Harmonization for Improving Cross-Site Generalization in Deep Learning Predictors

9. Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

10. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

11. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease

12. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

13. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning

14. Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia.

15. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies

16. Seizures as an early symptom of autosomal dominant Alzheimer's disease

17. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies

18. Structural signature of sporadic Creutzfeldt-Jakob disease.

19. Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease

20. Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease

21. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis

22. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis

23. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing

24. Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease

25. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

26. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease

27. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease

28. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study

29. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network

30. A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism

31. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease

32. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

33. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline.

34. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network

35. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease

36. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease

37. Pharmacology of modulators of alternative splicing

38. A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

39. Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice

40. Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice

41. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

42. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

43. Quantitative Amyloid imaging in autosomal Dominant Alzheimer's disease: Results from the DIAN study group

44. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease

45. The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells

47. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group

48. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group (vol 11, e0152082, 2016)

49. White Matter Hyperintensities Are a Core Feature of Alzheimer's Disease: Evidence from the Dominantly Inherited Alzheimer Network

50. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

Catalog

Books, media, physical & digital resources